Agilent Technologies and Ameritox Form Collaboration, Aim to Advance Analysis of Medication Monitoring Business Wire SANTA CLARA, Calif. & BALTIMORE -- February 11, 2013 Agilent Technologies Inc. (NYSE: A) and Ameritox^SM today announced that they have formed a research collaboration that could accelerate analysis in the field of medication monitoring. “By using multiple RapidFire systems Ameritox is streamlining the analysis of small panels of exogenous compounds compared to traditional methods of analysis,” said Can Ozbal, director of Agilent’s RapidFire business. While Agilent’s RapidFire system has been used extensively in pharmaceutical and biopharmaceutical laboratories, this research collaboration with Ameritox is one of the first for Agilent’s RapidFire team in the field of medication monitoring. “By working together and sharing moment-by-moment laboratory activity, this research arrangement gives both Ameritox and Agilent a vantage point from which we can continue to discover new uses for our science and technology,” said Jay Zimmerman, chief laboratory officer of Ameritox. “The marriage of Agilent’s technology and Ameritox’s proprietary science could hold the key to major advancements in the field of medication monitoring,” Zimmerman said. About Ameritox Ameritox is the nation’s leader in Pain Medication Monitoring Solutions^SM, offering specialized laboratory testing and reporting services. Ameritox’s expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers the most thorough pain medication monitoring lab process – Rx Guardian^SM – with Rx Guardian CD^SM, the only pain medication monitoring process with a proprietary normalization algorithm and a reference database of pain patients clinically assessed for adherence. Patient results are compared against this database, helping physicians assess whether patients are taking their pain medications correctly. Monitoring through prescription drug testing helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas and Greensboro, N.C. Ameritox can be found online at www.ameritox.com, on Twitter @Ameritox, on Facebook at facebook.com/ameritox, and on YouTube at www.youtube.com/ameritox. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company’s 20,500 employees serve customers in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal 2012. Information about Agilent is available at www.agilent.com. NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news. Contact: Agilent Susan Berg, +1-408-553-7093 email@example.com or Ameritox Lon Wagner, +1-336-387-7742 Lon.Wagner@ameritox.com
Agilent Technologies and Ameritox Form Collaboration, Aim to Advance Analysis of Medication Monitoring
Press spacebar to pause and continue. Press esc to stop.